Remote control-triggering of brain autoimmune disease in the gut

Current Opinion in Immunology

Volumn 25, Issue 6, 2013, Pages 683-689

  Wekerle, Hartmut ^a   Berer, Kerstin ^a   Krishnamoorthy, Gurumoorthy ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; BRAIN DISEASE; COMMENSAL; DIET; DISEASE ASSOCIATION; DISEASE MODEL; GASTROINTESTINAL TRACT; HUMAN; IMMUNE SYSTEM; INFECTION; INTESTINE FLORA; MULTIPLE SCLEROSIS; NONHUMAN; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WHITE MATTER;

ANIMALS; AUTOIMMUNE DISEASES; BRAIN DISEASES; CENTRAL NERVOUS SYSTEM; DIET; DISEASE MODELS, ANIMAL; GASTROINTESTINAL TRACT; HUMANS;

EID: 84889098870     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.09.009     Document Type: Review

References (64)

1. Diamond M. The World Until Yesterday: What Can We Learn from Traditional Societies? 2012, Viking Press, New York.
2. Sommer F., Bäckhed F. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol 2013, 11:227-238.
3. Maynard C.L., Elson C.O., Hatton R.D., Weaver C.T. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012, 489:231-241.
4. Sawcer S., Hellenthal G., Pirinen M., Spencer C.C.A., Patsopoulos N.A., Moutsianas L., Dilthey A., Su Z., Freeman C., Hunt S.E., et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219.
5. Krumbholz M., Derfuss T., Hohlfeld R., Meinl E. B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol 2012, 8:613-623.
6. Hohlfeld R. 'Gimme five': future challenges in multiple sclerosis. ECTRIMS Lecture 2009. MS 2010, 16:3-14.
7. Lassmann H., Wekerle H. The pathology of multiple sclerosis. McAlpine's Multiple Sclerosis 2006, 557-600. Elsevier, Churchill Livingstone. 4th ed. A. Compston, C. Confavreux, H. Lassmann, I. McDonald, D. Miller, J. Noseworthy, K. Smith, H. Wekerle (Eds.).
8. Madsen L.S., Andersson E.C., Jansson L., Krogsgaard M., Andersen C.B., Engsberg J., Strominger J.L., Svejgaard A., Holmdahl R., Wucherpfennig K.W., et al. A humanized model for multiple sclerosis using HLA DR2 and a human T cell receptor. Nat Genet 1999, 23:343-347.
9. Ben-Nun A., Wekerle H., Cohen I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 1981, 11:195-199.
10. Schluesener H.J., Wekerle H. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. J Immunol 1985, 135:3128-3130.
11. Martin R., Jaraquemada D., Flerlage M., Richert J.R., Whitaker J., Long E.O., McFarlin D.E., McFarland H.F. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 1990, 145:540-548.
12. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., Hafler D.A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990, 346:183-187.
13. Pette M., Fujita K., Wilkinson D., Altmann D.M., Trowsdale J., Giegerich G., Hinkkanen A., Epplen J.T., Kappos L., Wekerle H. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc Natl Acad Sci USA 1990, 87:7968-7970.
14. Klein L., Hinterberger M., von Rohrscheidt J., Aichinger M. Autonomous versus dendritic cell-dependent contributions of medullary thymic epithelial cells to central tolerance. Trends Immunol 2011, 32:188-192.
15. Naparstek Y., Ben-Nun A., Holoshitz J., Reshef T., Frenkel A., Rosenberg M., Cohen I.R. T lymphocyte line producing or vaccinating against autoimmune encephalomyelitis (EAE), functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur J Immunol 1983, 13:418-423.
16. Mills K.H.G. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011, 11:807-822.
17. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., Linington C. Animal models. Ann Neurol 1994, 36:S47-S53.
18. Kojima A., Tanaka-Kojima Y., Sakakura T., Nishizuka Y. Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab Invest 1976, 34:550-558.
19. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1060.
20. Krishnamoorthy G., Holz A., Wekerle H. Experimental models of spontaneous autoimmune disease in the central nervous system. J Mol Med 2007, 85:1161-1170.
21. Goverman J., Woods A., Larson L., Weiner L.P., Hood L., Zaller D.M. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993, 72:551-560.
22. Pöllinger B., Krishnamoorthy G., Berer K., Lassmann H., Bösl M., Dunn R., Domingues H.S., Holz A., Kurschus F.C., Wekerle H. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J Exp Med 2009, 206:1303-1310.
23. Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007, 61:288-299.
24. Kriesel J.D., Sibley W.A. The case for rhinoviruses in the pathogenesis of multiple sclerosis. MS 2005, 11:1-4.
25. Brundula V., Rewcastle N.B., Metz L.M., Bernard C.C., Yong V.W. Targeting leukocyte MMPs and transmigration-minocycline as a potential therapy for multiple sclerosis. Brain 2002, 125:1297-1300.
26. Popovic N., Schubart A., Goetz B.D., Zhang S.C., Linington C., Duncan I.D. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 2002, 51:215-223.
27. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999, 96:13496-13500.
28. Yokote H., Miyake S., Croxford J.L., Oki S., Mizusawa H., Yamamura T. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol 2008, 173:1714-1720.
29. Ochoa-Repáraz J., Mielcarz D.W., Ditrio L.E., Burroughs A.R., Foureau D.M., Haque-Begum S., Kasper L.H. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 2009, 183:6041-6050.
30. Ochoa-Repáraz J., Mielcarz D.W., Ditrio L.E., Burroughs A.R., Begum-Haque S., Dasgupta S., Kasper D.L., Kasper L.H. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol 2010, 185:4101-4110.
31. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2010, 108:4615-4620.
32. Berer K., Mues M., Koutroulos M., Al Rasbi Z., Boziki M., Johner C., Wekerle H., Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011, 479:538-541.
33. Lampropoulou V., Hoehlig K., Roch T., Neves P., Gómez E.C., Sweenie C.H., Hao Y., Freitas A.A., Steinhoff U., Anderton S.M., et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008, 180:4763-4770.
34. Maloy M.K., Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011, 474:298-306.
35. Hapfelmeier S., Lawson M.A.E., Slack E., Kirundi J.K., Stoel M., Heikenwalder M., Cahenzli J., Velykoredko Y., Balmer M.I., Endt K., et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010, 328:1705-1710.
36. Fagarasan S., Kinoshita K., Muramatsu M., Ikuta K., Honjo T. In situ class switching and differentiation to IgA producing cells in the gut lamina propria. Nature 2001, 413:639-643.
37. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
38. Vaishnava S., Behrendt C.L., Ismail A.S., Eckmann L., Hooper L.V. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci USA 2008, 105:20858-20860.
39. Fisher S.A., Tremelling M., Anderson C.A., Gwilliam R., Bumpstead S., Prescott N.J., Nimmo E.R., Massey D., Berzuini C., Johnson C., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nature Genet 2008, 40:710-712.
40. Petnicki-Ocwieja T., Hrncir T., Liu Y.J., Biswas A., Hudcovic T., Tlaskalová-Hogenová H., Kobayashi K.S. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA 2009, 106:15813-15820.
41. Walter J., Ley R.E. The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol 2011, 65:411-429.
42. Kim S.V., Xiang W.V., Kwak C., Yang Y., Lin X.W., Ota M., Sarpel U., Rifkin D.B., Xu R.L., Littman D.R. GPR15-mediated homing controls immune homeostasis in the large intestine mucosa. Science 2013, 340:1456-1459.
43. Abraham C., Ch J.H. Inflammatory bowel disease. N Engl J Med 2009, 361:2066-2070.
44. Gaboriau-Routhiau V., Rakotobe S., Lévuyer E., Mulder I., Lan A., Bridonneau C., Rochet V., Pisi A., De Paepe M., Brandi G., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31:677-689.
45. Ivanov I.I., Atarashi K., Manel N., Brodie F.L., Shima T., Karaoz U., Wei D.G., Goldfarb K.C., Santee C.A., Lynch S.V., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
46. Klaasen H.L.B.M., Koopman J.P., Poelma F.G.J., Beynen A.C. Intestinal, segmented, filamentous bacteria. Fems Microbiol Rev 1992, 88:165-179.
47. Kriegel M.A., Sefik E., Hill J.A., Wu H.-J., Benoist C., Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci USA 2011, 108:11548-11550.
48. Denning T.L., Norris B.A., Medina-Contreras O., Manicassamy S., Geem D., Madan R., Karp C.L., Pulendran B. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol 2011, 187:733-747.
49. Barnes M., Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009, 31:401-411.
50. Cebula A., Seweryn M., Rempala G.A., Pabla S.S., McIndoe R.A., Denning T.L., Bry L., Kraj P., Kisielow P., Ignatowicz L. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 2013, 497:258-262.
51. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., Cheng G.H., Yamasaki S., Saito T., Ohba Y., et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science 2011, 331:337-341.
52. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
53. Giongo A., Gano K.A., Crabb D.B., Mukherjee N., Novelo L.L., Casella G., Drew J.C., Ilonen J., Knip M., Hyoty H., et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011, 5:82-91.
54. Maslowski K.M., Vieira A.T., Ng A.W., Kranich J., Sierro F., Yu D., Schilter H., Rolph M.S., Mackay F., Artis D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1290.
55. Li Y., Innocentin S., Withers D.R., Roberts N.A., Gallagher A.R., Grigorieva E.F., Wilhelm C., Veldhoen M. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 2011, 147:629-640.
56. Spencer S.P., Belkaid Y. Dietary and commensal derived nutrients: shaping mucosal and systemic immunity. Curr Opin Immunol 2012, 24:379-384.
57. H17 cells. Nature 2013, 496:518-522.
58. H17 cells by inducible salt-sensing kinase SGK1. Nature 2013, 496:513-517.
59. Munger K.L., Zhang S.M., O'Reilly E., Hernan M.A., Olek M.J., Willett W.C., Ascherio A. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004, 62:60-65.
60. Compston A. Genetic epidemiology of multiple sclerosis. J Neurol Neurosurg Psych 1998, 62:553-561.
61. Osoegawa M., Kira J., Fukazawa T., Fujihara K., Kikuchi S., Matsui M., Kohriyama T., Sobue G., Yamamura T., Itoyama Y., et al. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. MS 2009, 15:159-173.
62. Lauer K. Diet and multiple sclerosis. Neurology 1997, 49(Suppl 2):S55-S61.
63. Wang D.J., Lu Z.Q., Hu L.P., Zhang Y.F., Hu X.Q. Macrolide antibiotics aggravate experimental autoimmune encephalomyelitis and inhibit inducible nitric oxide synthase. Immunol Invest 2009, 38:602-612.
64. Mor F., Cohen I.R. Beta-lactam antibiotics modulate T-cell functions and gene expression via covalent binding to cellular albumin. Proc Natl Acad Sci 2013, 110:2981-2990.